Peck Claas-Tido, Strauß Sarah, Stahl Gregory L, Vogt Peter-Maria, Busche Marc N
Hannover Medical School, Department of Plastic, Aesthetic, Hand, and Reconstructive Surgery, Hannover, Germany.
Harvard Medical School, Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Boston, MA, USA.
Innov Surg Sci. 2020 Sep 14;5(1-2):43-51. doi: 10.1515/iss-2020-0017. eCollection 2020 Mar.
Cutaneous ischemia/reperfusion (CI/R) injury has shown to play a significant role in chronic wounds such as decubitus ulcers, diabetic foot ulcers, atherosclerotic lesions, and venous stasis wounds. CI/R also plays a role in free tissue transfer in reconstructive microsurgery and has been linked to clinical burn-depth progression after thermal injury. While the role of the complement system has been elucidated in multiple organ systems, evidence is lacking with respect to its role in the skin. Therefore, we evaluated the role of the complement system in CI/R injury.
Using a single pedicle skin flap mouse model of acute CI/R, we performed CI/R in wild-type (WT) mice and complement knock out (KO) mice, deficient in either C1q (C1q KO; classical pathway inhibition), mannose-binding lectin (MBL null; lectin pathway inhibition) or factor B (H2Bf KO; alternative pathway inhibition). Following 10 h ischemia and 7 days reperfusion, mice were sacrificed, flaps harvested and flap viability assessed via Image J software. The flap necrotic area was expressed as % total flap area. In another group, mice were sacrificed following CI/R with 10 h ischemia and 48 h reperfusion. Two cranial skin flap samples were taken for gene expression analysis of IL1b, IL6, TNFα, ICAM1, VCAM1, IL10, IL13 using real-time polymerase chain reaction (RT-PCR).
Following CI/R, MBL null mice had a statistically significant smaller %necrotic flap area compared to WT mice (10.6 vs. 43.1%; p<0.05) suggesting protection from CI/R. A significantly reduced mean %necrotic flap area was not seen in either C1q KO or H2Bf KO mice relative to WT (22.9 and 31.3 vs. 43.1%; p=0.08 and p=0.244, respectively). There were no statistically significant differences between groups for markers of inflammation (TNFα, ICAM1, VCAM1, IL1b, IL6). In contrast, mRNA levels of IL10, a regulator of inflammation, were significantly increased in the MBL null group (p=0.047).
We demonstrated for the first time a significant role of MBL and the lectin complement pathway in ischemia/reperfusion injury of the skin and a potential role for IL10 in attenuating CI/R injury, as IL10 levels were significantly increased in the tissue from the CI/R-protected MBL null group.
皮肤缺血/再灌注(CI/R)损伤在慢性伤口如压疮、糖尿病足溃疡、动脉粥样硬化病变和静脉淤滞性伤口中起重要作用。CI/R在重建显微外科的游离组织移植中也起作用,并且与热损伤后的临床烧伤深度进展有关。虽然补体系统在多个器官系统中的作用已得到阐明,但关于其在皮肤中的作用尚缺乏证据。因此,我们评估了补体系统在CI/R损伤中的作用。
使用急性CI/R的单蒂皮瓣小鼠模型,我们在野生型(WT)小鼠和补体敲除(KO)小鼠中进行CI/R,这些小鼠分别缺乏C1q(C1q KO;经典途径抑制)、甘露糖结合凝集素(MBL缺失;凝集素途径抑制)或因子B(H2Bf KO;替代途径抑制)。缺血10小时和再灌注7天后,处死小鼠,取下皮瓣并通过Image J软件评估皮瓣活力。皮瓣坏死面积以占皮瓣总面积的百分比表示。在另一组中,在缺血10小时和再灌注48小时的CI/R后处死小鼠。取两个颅骨皮瓣样本,使用实时聚合酶链反应(RT-PCR)分析IL1b、IL6、TNFα、ICAM1、VCAM1、IL10、IL13的基因表达。
CI/R后,MBL缺失小鼠的坏死皮瓣面积百分比与WT小鼠相比在统计学上显著更小(10.6%对43.1%;p<0.05),表明对CI/R有保护作用。相对于WT小鼠,C1q KO或H2Bf KO小鼠均未观察到平均坏死皮瓣面积百分比显著降低(分别为22.9%和31.3%对43.1%;p=0.08和p=0.244)。炎症标志物(TNFα、ICAM1、VCAM1、IL1b、IL6)在各组之间无统计学显著差异。相反,炎症调节因子IL10的mRNA水平在MBL缺失组中显著升高(p=0.047)。
我们首次证明了MBL和凝集素补体途径在皮肤缺血/再灌注损伤中的重要作用,以及IL10在减轻CI/R损伤中的潜在作用,因为在CI/R保护的MBL缺失组的组织中IL10水平显著升高。